Raeanne C Moore1, Pariya L Fazeli2, Thomas L Patterson3, Colin A Depp4, David J Moore5, Eric Granholm6, Dilip V Jeste7, Brent T Mausbach8. 1. Department of Psychiatry, University of California San Diego, La Jolla, CA, 92093, USA; The Sam and Rose Stein Institute for Research on Aging, University of California San Diego, La Jolla, CA, 92093, USA. Electronic address: r6moore@ucsd.edu. 2. Department of Psychiatry, University of California San Diego, La Jolla, CA, 92093, USA. Electronic address: pfazeli@ucsd.edu. 3. Department of Psychiatry, University of California San Diego, La Jolla, CA, 92093, USA. Electronic address: tpatterson@ucsd.edu. 4. Department of Psychiatry, University of California San Diego, La Jolla, CA, 92093, USA; The Sam and Rose Stein Institute for Research on Aging, University of California San Diego, La Jolla, CA, 92093, USA; VA San Diego Healthcare System, San Diego, CA, 92161, USA. Electronic address: cdepp@ucsd.edu. 5. Department of Psychiatry, University of California San Diego, La Jolla, CA, 92093, USA. Electronic address: djmoore@ucsd.edu. 6. Department of Psychiatry, University of California San Diego, La Jolla, CA, 92093, USA; VA San Diego Healthcare System, San Diego, CA, 92161, USA. Electronic address: egranholm@ucsd.edu. 7. Department of Psychiatry, University of California San Diego, La Jolla, CA, 92093, USA; The Sam and Rose Stein Institute for Research on Aging, University of California San Diego, La Jolla, CA, 92093, USA. Electronic address: djeste@ucsd.edu. 8. Department of Psychiatry, University of California San Diego, La Jolla, CA, 92093, USA. Electronic address: bmausbach@ucsd.edu.
Abstract
OBJECTIVE: This study aimed to develop and validate a tablet mobile application version of the UCSD Performance-Based Skills Assessment (UPSA-M), a widely used test for assessing functional capacity in schizophrenia and other neurocognitively impaired patient populations. METHODS: The UPSA-M was developed for an iPad platform. Twenty-one middle-aged and older adults with schizophrenia and 13 healthy comparison (HC) participants completed abrief iPad tutorial, followed by the UPSA-M (full version, which includes all components of Brief UPSA-M) and a computer usage questionnaire. During a separate visit, patients with schizophrenia and HC participants completed the Brief UPSA (UPSA-B), and patients with schizophrenia completed a symptom inventory and brief neuropsychological screening battery. RESULTS: The UPSA-M was feasible for use among middle aged and older adults with schizophrenia with no prior history of tablet usage. The UPSA-M was able to differentiate between schizophrenia and HC participants 80% of the time, and this differential ability increased to 87% with the UPSA-M Brief. Traditional UPSA scores, UPSA-B scores, and neuropsychological performance were related to UPSA-M scores, whereas symptoms of psychopathology, experience with tablet technology, or difficulties operating the device were not significantly associated with UPSA-M. CONCLUSIONS: The UPSA-M performed just as well as the standard-of-practice version. These preliminary results indicate that the UPSA-M Brief has greater sensitivity than the full version of the UPSA-M, and carries the advantage of a shorter administration time. Overall, the UPSA-M appears to be a promising mobile tool to assess functional capacity.
RCT Entities:
OBJECTIVE: This study aimed to develop and validate a tablet mobile application version of the UCSD Performance-Based Skills Assessment (UPSA-M), a widely used test for assessing functional capacity in schizophrenia and other neurocognitively impaired patient populations. METHODS: The UPSA-M was developed for an iPad platform. Twenty-one middle-aged and older adults with schizophrenia and 13 healthy comparison (HC) participants completed a brief iPad tutorial, followed by the UPSA-M (full version, which includes all components of Brief UPSA-M) and a computer usage questionnaire. During a separate visit, patients with schizophrenia and HC participants completed the Brief UPSA (UPSA-B), and patients with schizophrenia completed a symptom inventory and brief neuropsychological screening battery. RESULTS: The UPSA-M was feasible for use among middle aged and older adults with schizophrenia with no prior history of tablet usage. The UPSA-M was able to differentiate between schizophrenia and HC participants 80% of the time, and this differential ability increased to 87% with the UPSA-M Brief. Traditional UPSA scores, UPSA-B scores, and neuropsychological performance were related to UPSA-M scores, whereas symptoms of psychopathology, experience with tablet technology, or difficulties operating the device were not significantly associated with UPSA-M. CONCLUSIONS: The UPSA-M performed just as well as the standard-of-practice version. These preliminary results indicate that the UPSA-M Brief has greater sensitivity than the full version of the UPSA-M, and carries the advantage of a shorter administration time. Overall, the UPSA-M appears to be a promising mobile tool to assess functional capacity.
Authors: Dilip V Jeste; Barton W Palmer; Paul S Appelbaum; Shahrokh Golshan; Danielle Glorioso; Laura B Dunn; Kathleen Kim; Thomas Meeks; Helena C Kraemer Journal: Arch Gen Psychiatry Date: 2007-08
Authors: Thomas L Patterson; Jesus Bucardo; Christine L McKibbin; Brent T Mausbach; David Moore; Concepcion Barrio; Sherrill R Goldman; Dilip V Jeste Journal: Schizophr Bull Date: 2005-07-21 Impact factor: 9.306
Authors: Eric Q Wu; Howard G Birnbaum; Lizheng Shi; Daniel E Ball; Ronald C Kessler; Matthew Moulis; Jyoti Aggarwal Journal: J Clin Psychiatry Date: 2005-09 Impact factor: 4.384
Authors: Eric Granholm; John R McQuaid; Fauzia Simjee McClure; Lisa A Auslander; Dimitri Perivoliotis; Paola Pedrelli; Thomas Patterson; Dilip V Jeste Journal: Am J Psychiatry Date: 2005-03 Impact factor: 18.112
Authors: D V Sheehan; Y Lecrubier; K H Sheehan; P Amorim; J Janavs; E Weiller; T Hergueta; R Baker; G C Dunbar Journal: J Clin Psychiatry Date: 1998 Impact factor: 4.384
Authors: Annemarijn C Prins-van Ginkel; Marieke LA de Hoog; C Uiterwaal; Henriette A Smit; Patricia Cj Bruijning-Verhagen Journal: JMIR Mhealth Uhealth Date: 2017-11-28 Impact factor: 4.773
Authors: Raeanne C Moore; Emily W Paolillo; Anne Heaton; Pariya L Fazeli; Dilip V Jeste; David J Moore Journal: PLoS One Date: 2017-08-24 Impact factor: 3.240
Authors: Kevin M Cummins; Ty Brumback; Tammy Chung; Raeanne C Moore; Trevor Henthorn; Sonja Eberson; Alyssa Lopez; Tatev Sarkissyan; Kate B Nooner; Sandra A Brown; Susan F Tapert Journal: JMIR Mhealth Uhealth Date: 2021-02-10 Impact factor: 4.773
Authors: Ghizlane Moussaoui; Ching Yu; Vincent Laliberté; Dominique Elie; Artin A Mahdanian; Benjamin Dawson; Marilyn Segal; Karl J Looper; Rej Soham Journal: Can Geriatr J Date: 2017-09-28
Authors: Shelagh Szabo; Elizabeth Merikle; Greta Lozano-Ortega; Lauren Powell; Thomas Macek; Stephanie Cline Journal: Schizophr Res Treatment Date: 2018-12-27